It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Open-lung ventilation during cardiopulmonary bypass (CPB) in patients undergoing heart transplantation (HTx) is a potential strategy to mitigate postoperative acute respiratory distress syndrome (ARDS). We utilized an ovine HTx model to investigate whether open-lung ventilation during CPB reduces postoperative lung damage and complications. Eighteen sheep from an ovine HTx model were included, with ventilatory interventions randomly assigned during CPB: the OPENVENT group received low tidal volume (VT) of 3 mL/kg and positive end-expiratory pressure (PEEP) of 8 cm H20, while no ventilation was provided in the NOVENT group as per standard of care. The recipient sheep were monitored for 6 h post-surgery. The primary outcome was histological lung damage, scored at the end of the study. Secondary outcomes included pulmonary shunt, driving pressure, hemodynamics and inflammatory lung infiltration. All animals completed the study. The OPENVENT group showed significantly lower histological lung damage versus the NOVENT group (0.22 vs 0.27, p = 0.042) and lower pulmonary shunt (19.2 vs 32.1%, p = 0.001). In addition, the OPENVENT group exhibited a reduced driving pressure (9.6 cm H2O vs. 12.8 cm H2O, p = 0.039), lower neutrophil (5.25% vs 7.97%, p ≤ 0.001) and macrophage infiltrations (11.1% vs 19.6%, p < 0.001). No significant differences were observed in hemodynamic parameters. In an ovine model of HTx, open-lung ventilation during CPB significantly reduced lung histological injury and inflammatory infiltration. This highlights the value of an open-lung approach during CPB and emphasizes the need for further clinical evidence to decrease risks of lung injury in HTx patients.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); Griffith University School of Medicine, Gold Coast, Australia (GRID:grid.1022.1) (ISNI:0000 0004 0437 5432); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
2 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Department of Anesthesia, Critical Care and Emergency, Milan, Italy (GRID:grid.414818.0) (ISNI:0000 0004 1757 8749)
3 Sunshine Coast University Hospital, Department of Anaesthesia and Perioperative Medicine, Birtinya, Australia (GRID:grid.510757.1) (ISNI:0000 0004 7420 1550)
4 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); North Estonia Medical Centre, Department of Intensive Care, Tallinn, Estonia (GRID:grid.454953.a) (ISNI:0000 0004 0631 377X)
5 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); Griffith University, School of Pharmacy and Medical Sciences, Southport, Australia (GRID:grid.1022.1) (ISNI:0000 0004 0437 5432)
6 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); Cardiovascular Research Institute Basel, Basel, Switzerland (GRID:grid.410567.1) (ISNI:0000 0001 1882 505X)
7 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
8 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); Queensland University of Technology, School of Mechanical, Medical and Process Engineering, Faculty of Engineering, Brisbane, Australia (GRID:grid.1024.7) (ISNI:0000 0000 8915 0953)
9 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); Princess Alexandra Hospital, Department of Anaesthesia and Medical Perfusion & Department of Intensive Care, Brisbane, Australia (GRID:grid.412744.0) (ISNI:0000 0004 0380 2017)
10 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); Wellcome Trust Centre for Global Health Research, Imperial College London, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); Initiative to Develop African Research Leaders (IdeAL), Kilifi, Kenya (GRID:grid.7445.2)
11 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); The Prince Charles Hospital, Department of Anaesthesia and Perfusion, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266)
12 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); Korea University, Department of Thoracic and Cardiovascular Surgery, College of Medicine, Seoul, Republic of Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678)
13 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); Queensland University of Technology, School of Public Health and Social Work, Faculty of Health, Brisbane, Australia (GRID:grid.1024.7) (ISNI:0000 0000 8915 0953)
14 The University of Queensland, School of Veterinary Science, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
15 The Alfred Hospital, Department of Anesthesia, Melbourne, Australia (GRID:grid.1623.6) (ISNI:0000 0004 0432 511X)
16 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); University of Queensland, School of Biomedical Sciences, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); Griffith University, School of Pharmacy and Medical Sciences, Southport, Australia (GRID:grid.1022.1) (ISNI:0000 0004 0437 5432)
17 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); The Alfred Hospital, Cardiothoracic Surgery and Transplantation, Melbourne, Australia (GRID:grid.1623.6) (ISNI:0000 0004 0432 511X); Monash University, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
18 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); Queensland University of Technology, Brisbane, Australia (GRID:grid.1024.7) (ISNI:0000 0000 8915 0953); St Andrew’s War Memorial Hospital, Intensive Care Unit, Spring Hill, Australia (GRID:grid.517823.a) (ISNI:0000 0000 9963 9576)
19 The Prince Charles Hospital, Critical Care Research Group, Brisbane, Australia (GRID:grid.415184.d) (ISNI:0000 0004 0614 0266); University of Queensland, Faculty of Medicine, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537); Princess Alexandra Hospital, Department of Anaesthesia and Medical Perfusion & Department of Intensive Care, Brisbane, Australia (GRID:grid.412744.0) (ISNI:0000 0004 0380 2017); Queensland University of Technology, Brisbane, Australia (GRID:grid.1024.7) (ISNI:0000 0000 8915 0953); St Andrew’s War Memorial Hospital, Intensive Care Unit, Spring Hill, Australia (GRID:grid.517823.a) (ISNI:0000 0000 9963 9576); Wesley Medical Research, Brisbane, Australia (GRID:grid.431722.1); The Wesley Hospital, Intensive Care Unit, Auchenflower, Australia (GRID:grid.417021.1) (ISNI:0000 0004 0627 7561)